Magnesium Alloy Testing Patents: Leaders, Trends & White Space 2026
- Filing has plateaued, not grown. Activity peaked at 6 families in 2024 after sitting flat around 3-4 a year since 2017 — this is a mature, occupied claim space rather than an emerging one.
- Corrosion-resistant biodegradable alloys dominate citations. The most-cited records in this set are implant-grade magnesium alloys, not industrial inspection methods, showing where prior influence actually concentrates.
- Filing is US-and-China-led with a thin PCT layer. United States and China together account for the bulk of receiving-office activity, while only 5 families route through WIPO — most protection stays jurisdiction-bound.
What this landscape covers
This dataset tracks patent families at the intersection of magnesium alloy composition and testing or inspection methods — ultrasonic inspection, mechanical testing, corrosion testing and defect detection — filed against IPC classes covering alloys, metal treatment and physical measurement (C22C23/00, G01N29, G01N3). It spans 2015 through the middle of 2026, with 48 published families forming the base for every ranking and trend on this page.
Because publication typically lags filing by around 18 months, the most recent year of data is necessarily incomplete and should be read as a floor, not a ceiling. The dataset favours records that combine alloy claims with an explicit testing or inspection method, so it under-represents pure alloy-composition filings that make no inspection claim at all.
Filing trend and technology composition
Two views of the same 48-family dataset: how filing volume has moved year over year, and which IPC subclasses carry the technical weight.
Filing trend: flat with a recent peak
Filings moved from 3 in 2017 to a peak of 6 in 2024, with the 2022 midpoint sitting at 4 — a pattern consistent with a steady, low-volume niche rather than an accelerating one. The partial 2026 count of 1 reflects publication lag, not a real drop-off.
IPC composition: alloys and treatment dominate
C22C (alloys) and C22F (non-ferrous metal treatment) anchor the dataset at 42 and 26 records respectively. Casting (B22D), heat treatment (C21D), sterilising (A61L), powder metallurgy (B22F), nanotechnology (B82Y) and even foundations/earth drilling (E02D) each contribute a handful of records, pointing to biomedical-implant and structural-component use cases sitting alongside the core alloy-testing claims.
Shares are the percentage of the 48 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Magnesium Alloy Testing and Inspection with Eureka
This page is one run against one query. Ask Eureka your own question about magnesium alloy testing and inspection and every answer comes back with the patent numbers behind it.
Try EurekaRepresentative filing and citation leaders
EP2535435A1 — Magnesium Alloy Sheet (Sumitomo Electric Industries)
A magnesium alloy sheet made of a magnesium alloy containing Al, with particles of an intermetallic compound containing at least one of Al and Mg dispersed through the sheet. The sheet carries a uniform oxide film across its surface, with intermetallic particle size capped at 0.5 µm or less and total particle area at 11% or less, giving the sheet improved corrosion resistance. The filing also covers a magnesium alloy structural member built from this sheet.Filed by Sumitomo Electric Industries, dated 2012-12-19.
| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US20170268088A1 | High Conductivity Magnesium Alloy | 55 |
| 2 | US20100082092A1 | Implant Made of a Biodegradable Magnesium Alloy | 33 |
| 3 | CN111450322A | 一种医用可降解多层Mg/Zn复合材料及其制备方法 | 21 |
| 4 | US20130060326A1 | Implant made of a biodegradable magnesium alloy | 16 |
| 5 | WO2017205281A1 | High conductivity magnesium alloy | 15 |
| 6 | US5139077A | Ingot cast magnesium alloys with improved corrosion resistance | 14 |
| 7 | US4908181A | Ingot cast magnesium alloys with improved corrosion resistance | 12 |
| 8 | US20190338405A1 | High Conductivity Magnesium Alloy | 10 |
| 9 | CN2789767Y | 空气超声探头 | 9 |
| 10 | CN219245251U | 一种可温控镁合金应力腐蚀试验装置 | 6 |
Citation counts reflect influence within the searched corpus and skew toward older filings; treat them as a signal of historical weight, not current commercial priority.
Patent titles are shown in the language they were filed in, not translated, so that each record stays verifiable against the original filing — a translated title will not match in Eureka or in any national register. Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the data signals
Reading the filing trend, citation pattern and IPC spread together points to a niche that rewards precision over volume.
A steady, low-volume field
Filings never exceeded single digits in any year of this dataset. That is not a sign of low importance — it means the claim space is narrow enough that a handful of well-drafted families can occupy most of it.
Influence sits with biodegradable implant alloys
The most-cited records in this corpus are high-conductivity and biodegradable magnesium alloy patents rather than inspection-method patents, suggesting the testing claims that matter most are the ones written around implant-grade corrosion behaviour.
Protection is regional, not global
With only 5 families filed through WIPO's PCT route, most applicants are choosing to protect magnesium alloy testing inventions directly in the US, China or Europe rather than building a broad international family.
Collaboration is rare and clustered
Only four co-assignee pairs appear across the dataset, and the strongest links all sit within one cluster of Chinese oil and gas entities — a sign that most other filers are working alone rather than through joint filings.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to magnesium alloy testing and inspection, with the prior art for and against each one.
Who is filing, and how active are they now
Assignee activity in this dataset is broad rather than concentrated, with several historically active filers showing no output in the latest tracked year.
Recent-year activity has gone quiet
Several assignees with a filing history in this space, including CNPC USA Corp with a -100% year-on-year change, show zero filings in the most recent tracked year. Read this alongside the 18-month publication lag before concluding activity has actually stopped.
One cluster drives most joint filing
The strongest co-assignee relationships in the dataset all involve the same small group of Chinese oil-and-gas-linked entities, suggesting collaborative filing here is need-driven rather than a broader industry norm.
Biomedical and industrial filers overlap
The presence of sterilising/disinfecting (A61L) and powder metallurgy (B22F) alongside core alloy classes shows this dataset spans both structural/industrial and biomedical-implant filers rather than a single industry vertical.
| Assignee | Recent year | YoY |
|---|---|---|
| TRW Inc. | 0 | — |
| BYD Company Limited | 0 | — |
| Fort Wayne Metals Research Products Corp | 0 | — |
| Sumitomo Electric Industries, Ltd. | 0 | — |
| CNPC USA CORP | 0 | -100% |
| Hewlett-Packard Development Company, L.P. | 0 | — |
| Beijing Huamei Century International Technology Co., Ltd. | 0 | -100% |
| China National Petroleum Corporation (CNPC) | 0 | -100% |
Where to take this analysis
The dataset points to specific next steps for teams deciding where to file or where to design around existing claims.
Map claim scope against the top-cited families
Before drafting new claims in corrosion-resistant or biodegradable Mg alloys, check exact claim language on the highest-cited records to see how tightly particle size and area percentage limits are already locked down.
Explore claim charts in EurekaWatch the quiet assignees for renewed activity
Several previously active filers show zero output in the latest year. A renewed filing from any of them would signal a shift worth tracking closely given the field's low overall volume.
Set up assignee tracking in EurekaTest the under-claimed branches for freedom to operate
The gate chips above mark technical branches with thin filing density in this corpus. Each merits its own freedom-to-operate check before committing R&D spend.
Run a white space search in EurekaCommon questions on magnesium alloy testing patents
This dataset tracks 48 patent families filed between 2015 and mid-2026 that combine magnesium alloy composition claims with testing or inspection methods such as ultrasonic inspection, mechanical testing and corrosion testing. That figure reflects a specific IPC and keyword search and will differ from broader magnesium alloy searches that do not require an explicit testing or inspection claim. Filing volume has stayed in the single digits every year, peaking at 6 families in 2024.
Activity is spread across a mix of biomedical implant makers, industrial metals firms and a small cluster of Chinese oil-and-gas-linked entities that co-file together. No single assignee dominates the full 48-family set, and several previously active filers, including CNPC USA Corp, show zero filings in the latest tracked year. The most-cited individual records come from Sumitomo Electric Industries and biodegradable-implant alloy filings.
The top-cited record in this dataset is US20170268088A1, 'High Conductivity Magnesium Alloy', with 55 citations, followed by US20100082092A1 covering a biodegradable magnesium alloy implant with 33 citations. High citation counts in a searched corpus tend to favour older filings that have simply had more time to accumulate citing references, so treat them as a marker of historical influence rather than current commercial priority.
Comparatively thin filing density shows up around in-situ ultrasonic corrosion monitoring, defect detection tailored to additively manufactured magnesium parts, and fatigue testing specific to biodegradable implants. These branches sit adjacent to the dense core of alloy composition and corrosion-testing claims but are not yet heavily occupied in this dataset. A freedom-to-operate check on any of these branches should still confirm current filing status before committing resources, since publication lag means the newest filings are not yet visible.
The filing trend in this dataset moves from 3 families in 2017 to a peak of 6 in 2024, with the 2022 midpoint at 4 — a pattern of steady, low-volume activity rather than clear growth or decline. Because publication typically lags filing by around 18 months, the partial count of 1 for 2026 understates real activity for that year rather than indicating an actual drop. A narrow, mature niche like this can sustain a small number of filers indefinitely without ever showing dramatic year-over-year swings.
Research Magnesium Alloy Testing and Inspection in depth with Eureka
Go past this page: query the whole magnesium alloy testing and inspection corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.